Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'thrombin inhibitor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 216 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. White, R; Rusconi, C; Scardino, E; Wolberg, A; Lawson, J; Hoffman, M; Sullenger, B
      Generation of species cross-reactive aptamers using "toggle" SELEX

      MOLECULAR THERAPY
    2. Schatteman, KA; Goossens, FJ; Leurs, J; Kasahara, Y; Scharpe, SS; Hendriks, DF
      Fast homogeneous assay for plasma procarboxypeptidase U

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    3. Steinmetzer, T; Hauptmann, J; Sturzebecher, J
      Advances in the development of thrombin inhibitors

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Coburn, CA
      Small-molecule direct thrombin inhibitors: 1997-2000

      EXPERT OPINION ON THERAPEUTIC PATENTS
    5. Oldgren, J; Linder, R; Grip, L; Siegbahn, A; Wallentin, L
      Coagulation activity and clinical outcome in unstable coronary artery disease

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    6. Van Aken, H; Bode, C; Darius, H; Diehm, C; Encke, M; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schror, K; Schulte, KL; Tebbe, U
      Anticoagulation: The present and future

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    7. Schatteman, K; Goossens, F; Leurs, J; Verkerk, R; Scharpe, S; Michiels, JJ; Hendriks, D
      Carboxypeptidase U at the interface between coagulation and fibrinolysis

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    8. Kondo, LM; Wittkowsky, AK; Wiggins, BS
      Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia

      ANNALS OF PHARMACOTHERAPY
    9. Amino, R; Tanaka, AS; Schenkman, S
      Triapsin, an unusual activatable serine protease from the saliva of the hematophagous vector of Chagas' disease Triatoma infestans (Hemiptera : Reduviidae)

      INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    10. Li, S; Kwon, J; Aksoy, S
      Characterization of genes expressed in the salivary glands of the tsetse fly, Glossina morsitans morsitans

      INSECT MOLECULAR BIOLOGY
    11. Hoffmann, JJML; Janssen, WCM
      Comparison of three methods for measuring PEG-hirudin in blood

      BLOOD COAGULATION & FIBRINOLYSIS
    12. Valls, N; Lopez-Canet, M; Vallribera, M; Bonjoch, J
      First total syntheses of aeruginosin 298-A and aeruginosin 298-B, based ona stereocontrolled route to the new amino acid 6-hydroxyoctahydroindole-2-carboxylic

      CHEMISTRY-A EUROPEAN JOURNAL
    13. Hryszko, T; Malyszko, J; Malyszko, JS; Brzosko, S; Pawlak, K; Mysliwiec, M
      A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    14. Moledina, M; Chakir, M; Gandhi, PJ
      A synopsis of the clinical uses of argatroban

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    15. Weitz, JI
      New anticoagulant drugs

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    16. Mosnier, LO; Lisman, T; van den Berg, HM; Nieuwenhuis, HK; Meijers, JCM; Bouma, BN
      The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration

      THROMBOSIS AND HAEMOSTASIS
    17. Mattsson, C; Menschiek-Lundin, A; Wahlander, K; Lindahl, TL
      Effect of melagatran on prothrombin time assays depends on the sensitivityof the thromboplastin and the final dilution of the plasma sample

      THROMBOSIS AND HAEMOSTASIS
    18. Sheth, SB; DiCicco, RA; Hursting, MJ; Montague, T; Jorkasky, DK
      Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin

      THROMBOSIS AND HAEMOSTASIS
    19. Lahann, J; Klee, D; Pluester, W; Hoecker, H
      Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices

      BIOMATERIALS
    20. Mikulski, A; Elg, M; Gustafsson, D
      The effects of oral and intravenous direct thrombin inhibitors on the sizeof photochemically induced cortical infarction in rats

      THROMBOSIS RESEARCH
    21. Qi, R; Yatomi, Y; Ozaki, Y
      Effects of incubation time, temperature, and anticoagulants on platelet aggregation in whole blood

      THROMBOSIS RESEARCH
    22. Elg, M; Carlsson, S; Gustafsson, D
      Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor

      THROMBOSIS RESEARCH
    23. Elg, M; Carlsson, S; Gustafsson, D
      Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits

      THROMBOSIS RESEARCH
    24. Gustafsson, D; Nystrom, JE; Carlsson, S; Bredberg, U; Eriksson, U; Gyzander, E; Elg, M; Antonsson, T; Hoffmann, KJ; Ungell, AL; Sorensen, H; Nagard, S; Abrahamsson, A; Bylund, R
      The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: Intestinal absorption properties, biochemical and pharmacodynamic effects

      THROMBOSIS RESEARCH
    25. Morris, DC; Zhang, L; Zhang, ZG; Lu, M; Berens, KL; Brown, PM; Chopp, M
      Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke

      STROKE
    26. Fareed, J; Shaikh, T; Hoppensteadt, DA
      Antithrombin and anti-Xa agents in the control of thrombogenesis

      PHARMAZIE
    27. Salzet, M
      Anticoagulants and inhibitors of platelet aggregation derived from leeches

      FEBS LETTERS
    28. McKeage, K; Plosker, GL
      Argatroban

      DRUGS
    29. Weitz, JI; Hirsh, J
      New anticoagulant drugs

      CHEST
    30. Lauer, MA; Houghtaling, PL; Peterson, JG; Granger, CB; Bhatt, DL; Sapp, SK; Simoons, ML; Harrington, RA; Topol, EJ; Lincoff, AM
      Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acutecoronary syndromes - Observations from the platelet IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial

      CIRCULATION
    31. Nishida, H; Miyazaki, Y; Kitamura, Y; Ohashi, M; Matsusue, T; Okamoto, A; Hosaka, Y; Ohnishi, S; Mochizuki, H
      Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor

      CHEMICAL & PHARMACEUTICAL BULLETIN
    32. Baskova, IP; Zavalova, LL
      Proteinase inhibitors from the medicinal leech Hirudo medicinalis

      BIOCHEMISTRY-MOSCOW
    33. Levine, GN; Ali, MN; Schafer, AI
      Antithrombotic therapy in patients with acute coronary syndromes

      ARCHIVES OF INTERNAL MEDICINE
    34. Antman, EM; Braunwald, E
      A second look at bivalirudin

      AMERICAN HEART JOURNAL
    35. Levy, JP
      Novel intravenous antithrombins

      AMERICAN HEART JOURNAL
    36. Supuran, CT; Briganti, F; Scozzafava, A; Ilies, MA
      Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitorsincorporating pyridinium-sulfanilylaminoguanidine moieties

      JOURNAL OF ENZYME INHIBITION
    37. Colin, S; Vaysse-Ludot, L; Lecouve, JP; Maddaluno, J
      Combining high pressure and catalysis: pinacol- or catecholborane hydroboration of functionalized olefins

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    38. Song, HC; Gu, XM; Riffel, K; Yan, K; Lo, MW
      Determination of a novel thrombin inhibitor in human plasma and urine utilizing Liquid chromatography with tandem mass spectrometric and ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    39. Scatena, R
      Bivalirudin: a new generation antithrombotic drug

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    40. Juhan-Vague, I; Renucci, JF; Grimaux, M; Morange, PE; Gouvernet, J; Gourmelin, Y; Alessi, MC
      Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    41. Kudo, A; Suzuki, M; Kubo, Y; Watanabe, M; Yoshida, K; Doi, M; Kuroda, K; Ogawa, A
      Intrathecal administration of thrombin inhibitor ameliorates cerebral vasospasm - Use of a drug delivery system releasing hirudin

      CEREBROVASCULAR DISEASES
    42. Dougan, H; Lyster, DM; Vo, CV; Stafford, A; Weitz, JI; Hobbs, JB
      Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood

      NUCLEAR MEDICINE AND BIOLOGY
    43. Hanessian, S; Balaux, E; Musil, D; Olsson, LL; Nilsson, I
      Exploring the chiral space within the active site of alpha-thrombin with aconstrained mimic of D-Phe-Pro-Arg - Design, synthesis, inhibitory activity, and x-ray structure of an enzyme-inhibitor complex

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    44. Li, WR; Lin, ST; Yang, JH
      An expedient N-termimal attachment methodology for the solid phase peptidesynthesis

      SYNLETT
    45. Vermeer, F; Vahanian, A; Fels, PW; Besse, P; Muller, E; Van de Werf, F; Fitzgerald, D; Darius, H; Puel, J; Garrigou, D; Simoons, ML
      Argatroban and alteplase in patients with acute myocardial infarction: TheARGAMI study

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    46. Komatsu, Y; Hayashi, H
      Most clot-bound thrombin activity is inhibited by plasma antithrombin during clot aging, but a very small fraction survives

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    47. Kumura, T; Hino, M; Yamane, T; Tatsumi, N
      Argatroban as an anticoagulant for both hematologic and chemical tests

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    48. Onomura, M; Tsukada, H; Fukuda, K; Kodama, M; Nakamura, H; Hosokawa, M; Ohya, M; Seino, Y
      Effect of argatroban on trinitrobenzene sulfonic acid-induced colitis

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    49. Riffel, KA; Song, HC; Gu, XM; Yan, K; Lo, MW
      Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    50. Guo, XY; Okada, N; Okada, H
      CPR-total (TAFI and activated TAFI) levels in plasma/serum of hemophiliacs

      MICROBIOLOGY AND IMMUNOLOGY
    51. Li, S; Aksoy, S
      A family of genes with growth factor and adenosine deaminase similarity are preferentially expressed in the salivary glands of Glossina m. morsitans

      GENE
    52. Rusconi, CP; Yeh, A; Lyerly, HK; Lawson, JH; Sullenger, BA
      Blocking the initiation of coagulation by RNA aptamers to factor VIIa

      THROMBOSIS AND HAEMOSTASIS
    53. Friederich, PW; Keller, TT; Biemond, BJ; Peters, RJG; Hornberger, W; Buller, HR; Levi, M
      Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor

      THROMBOSIS AND HAEMOSTASIS
    54. Berry, CN; Lunven, C; Lecoffre, C; Lainee, P; O'Connor, SE; Andre, F; Roger, B; Garrigou-Gadenne, D; Rouchouse, A; Roome, NO; Vivan, N
      Anticoagulant activity and pharmacokinetic properties of a sub-cutaneouslyadministered mixed micellar formulation of argatroban in experimental animals

      THROMBOSIS AND HAEMOSTASIS
    55. Marx, PF; Wagenaar, GTM; Reijerkerk, A; Tiekstra, MJ; van Rossum, AGSH; Gebbink, MFBG; Meijers, JCM
      Characterization of mouse thrombin-activatable fibrinolysis inhibitor

      THROMBOSIS AND HAEMOSTASIS
    56. Matsuo, T; Matsuo, M; Kario, K; Suzuki, S
      Characteristics of heparin-induced platelet aggregates in chronic hemodialysis with long-term heparin use

      HAEMOSTASIS
    57. Swan, SK; St Peter, JV; Lambrecht, LJ; Hursting, MJ
      Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects

      PHARMACOTHERAPY
    58. Richardson, JL; Kroger, B; Hoeffken, W; Sadler, JE; Pereira, P; Huber, R; Bode, W; Fuentes-Prior, P
      Crystal structure of the human alpha-thrombin-haemadin complex: an exositeII-binding inhibitor

      EMBO JOURNAL
    59. Koh, YS; Chung, KH; Kim, DS
      Purification and cDNA cloning of salmorin that inhibits fibrinogen clotting

      THROMBOSIS RESEARCH
    60. Suzuki, S; Matsuo, T; Kobayashi, H; Matsuo, M; Shimamo, C; Koide, M; Sakamoto, S
      Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: Effects on inflammatory, hemostatic, and endothelium-derived parameters

      THROMBOSIS RESEARCH
    61. Giardino, EC; Costanzo, MJ; Kauffman, JA; Li, QS; Maryanoff, BE; Andrade-Gordon, P
      Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor

      THROMBOSIS RESEARCH
    62. Leblond, L; Grouix, B; Boudreau, C; Yang, Q; Siddiqui, MA; Winocour, PD
      In vitro and in vivo properties of bicyclic lactam inhibitors: A novel class of low molecular weight peptidomimetic thrombin inhibitors

      THROMBOSIS RESEARCH
    63. Lyon, ME; Harding, SR; Oosman, SN; Lyon, AW
      Evaluation of argatroban and DUP 714 as anticoagulants for blood gas, electrolyte and ionized calcium analyses

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    64. Leung, D; Abbenante, G; Fairlie, DP
      Protease inhibitors: Current status and future prospects

      JOURNAL OF MEDICINAL CHEMISTRY
    65. White, RR; Sullenger, BA; Rusconi, CP
      Developing aptamers into therapeutics

      JOURNAL OF CLINICAL INVESTIGATION
    66. Maeno, T; Tano, Y; Mano, T; Takenaka, H
      Argatroban inhibits intraocular fibrin formation after vitrectomy in rabbits

      ARCHIVES OF OPHTHALMOLOGY
    67. Horn, F; dos Santos, PC; Termignoni, C
      Boophilus microplus anticoagulant protein: An antithrombin inhibitor isolated from the cattle tick saliva

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    68. Monteiro, RQ; Zingali, RB
      Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    69. Frederiksen, JW
      Cardiopulmonary bypass in humans: Bypassing unfractionated heparin

      ANNALS OF THORACIC SURGERY
    70. Geiger, J
      Anti-aggregatory drugs: I. Platelet receptor antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    71. Vogt, A
      Antiplatelet drugs plus thrombolysis in myocardial infarction - Where are we now?

      BIODRUGS
    72. Ahmad, S; Ahsan, A; George, M; Iqbal, O; Jeske, WP; McKenna, R; Lewis, BE; Walenga, JM; Fareed, J
      Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: Potential clinical applications

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    73. Rade, JJ; Cheung, M; Miyamoto, S; Dichek, DA
      Retroviral vector-mediated expression of hirudin by human vascular endothelial cells: implications for the design of retroviral vectors expressing biologically active proteins

      GENE THERAPY
    74. Sakai, M; Ohteki, H; Narita, Y; Naitoh, K; Natsuaki, M; Itoh, T
      Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model

      CARDIOVASCULAR SURGERY
    75. Pini, M
      Future prospects of prophylaxis for deep vein thrombosis

      BLOOD COAGULATION & FIBRINOLYSIS
    76. Rodriguez, G; Gallardo, A; San Roman, J; Rebuelta, M; Bermejo, P; Bujan, J; Bellon, JM; Honduvilla, NG; Escudero, C
      New resorbable polymeric systems with antithrombogenic activity

      JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
    77. Kim, HO; Kahn, M
      The synthesis of aminoazole analogs of lysine and arginine: The Mitsunobu reaction with lysinol and argininol

      SYNLETT
    78. Ueki, Y; Matsumoto, K; Kizaki, Y; Yoshida, K; Matsunaga, Y; Yano, M; Miyake, S; Tominaga, Y; Eguchi, K
      Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: Placebo-controlled study

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    79. McClanahan, TB; Ignasiak, DP; Juneau, P; Finkle, C; Winocour, PD; Gallagher, KP
      Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosis

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    80. Saitoh, H; Aungst, BJ
      Improvement of the intestinal absorption of a peptidomimetic, boronic acidthrombin inhibitor possibly utilizing the oligopeptide transporter

      PHARMACEUTICAL RESEARCH
    81. Sjostrom, M; Lindfors, L; Ungell, AL
      Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancement

      PHARMACEUTICAL RESEARCH
    82. Ahmad, S; Iqbal, O; Ahsan, A; Hoppensteadt, DA; Lewis, BE; Walenga, JM; Fareed, J
      Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using High Performance Liquid Chromatography and functional methods

      INTERNATIONAL ANGIOLOGY
    83. Lange, U; Keilholz, W; Schaub, GA; Landmann, H; Markwardt, F; Nowak, G
      Biochemical characterization of a thrombin inhibitor from the bloodsuckingbug Dipetalogaster maximus

      HAEMOSTASIS
    84. Scozzafava, A; Briganti, F; Supuran, CT
      Protease inhibitors - Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    85. Walenga, JM; Fasanella, AR; Iqbal, O; Hoppensteadt, DA; Ahmad, S; Wallis, DE; Bakhos, M
      Coagulation laboratory testing in patients treated with argatroban

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    86. Walenga, JM; Jeske, WP; Wallis, DE; Bakhos, M; Lewis, BE; Leya, F; Fareed, J
      Clinical experience with combined treatment of thrombin inhibitors and GPIIb IIIa inhibitors in patients with HIT

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    87. Tran, JQ; Di Cicco, RA; Sheth, SB; Tucci, M; Peng, L; Jorkasky, DK; Hursting, MJ; Benincosa, LJ
      Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban

      JOURNAL OF CLINICAL PHARMACOLOGY
    88. Linder, R; Blomback, M; Egberg, N; Grip, L
      Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C

      THROMBOSIS RESEARCH
    89. Leblond, L; DiMaio, J; Winocour, PD
      Insertion of the Asp-Ser/Phe sequence in the P ' position of hirutonin provides molecules having both antithrombin and disintegrin activity

      THROMBOSIS RESEARCH
    90. Castro, HC; Fernandes, M; Zingali, RB
      Identification of Bothrojaracin-like proteins in snake venoms from Bothrops species and Lachesis muta

      TOXICON
    91. Tanaka, AS; Silva, MM; Torquato, RJS; Noguti, MAE; Sampaio, CAM; Fritz, H; Auerswald, EA
      Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors

      FEBS LETTERS
    92. Nienaber, J; Gaspar, ARM; Neitz, AWH
      Savignin, a potent thrombin inhibitor isolated from the salivary glands ofthe tick Ornithodoros savignyi (Acari : Argasidae)

      EXPERIMENTAL PARASITOLOGY
    93. Mende, K; Petoukhova, O; Koulitchkova, V; Schaub, GA; Lange, U; Kaufmann, R; Nowak, G
      Dipetalogastin, a potent thrombin inhibitor from the blood-sucking insect Dipetalogaster maximus - cDNA cloning, expression and characterization

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    94. Lyon, ME; Drobot, DW; Harding, SR; Lyon, AW
      Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) as anticoagulants for critical care clinical chemistry specimens

      CLINICA CHIMICA ACTA
    95. Tideman, PA
      Antithrombins and the importance of good control

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    96. Kerns, RT; Kini, RM; Stefansson, S; Evans, HJ
      Targeting of venom phospholipases: The strongly anticoagulant phospholipase A(2) from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    97. Sabatine, MS; Jang, IK
      Antithrombotic therapy in acute coronary syndromes

      ACTA CARDIOLOGICA

    98. ANTITHROMBOTIC DIAMINES

      Expert opinion on therapeutic patents
    99. AHMAD S; AHSAN A; IQBAL O; HOPPENSTEADT DA; LEWIS BE; WALENGA JM; FAREED J
      PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULAR PATIENTS

      Clinical and applied thrombosis/hemostasis
    100. CACIAGLI V; CARDINALI F; BONELLI F; LOMBARDI P
      LARGE-SCALE PRODUCTION OF PEPTIDES USING THE SOLID-PHASE CONTINUOUS-FLOW METHOD - PART 2 - PREPARATIVE SYNTHESIS OF A 26-MER PEPTIDE THROMBIN INHIBITOR

      Journal of peptide science


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 17:47:58